Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of patients with HBeAg-negative chronic hepatitis B virus infection: a randomised, double-blind, phase 3, non-inferiority trial - Buti, M; Gane, E; Seto, W K (Lancet Gastroenterol Hepatol, 2016)
et al.